profit from every $100 of sales.
$0$100
Heartflow
$48.46-19.13% today
+77.4% in 1 year
1-year low $20.491-year high $60.53
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Heartflow sold, what it kept, and what it did with the cash.
Sales went from $87.2 million in 2023 to $176 million in 2025, with -$117 million of profit last year.
SalesProfit
Heartflow vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Heartflow | No profit yet | ||
 Veeva Systems | 53.7× · Expensive | ||
 Pro Medicus | 183.7× · Very expensive | ||
 Hinge Health | No profit yet | ||
 M3 | 30.1× · Expensive |
AI analysis
An AI analyst reads Heartflow's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2023 | 2024 | 2025 |
|---|---|---|---|
| 87 | 126 | 176 | |
| 58 | 94 | 135 | |
| -73 | -61 | -64 | |
| -63 | -66 | -93 | |
| -96 | -96 | -117 | |
| -1.94 | -1.20 | -3.17 | |
| 66.6% | 75.1% | 76.8% | |
| -83.6% | -48.7% | -36.4% | |
| -109.7% | -76.6% | -66.3% |
Balance sheet
| In millions of USD | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 185 | 119 | 359 |
| Cash | 123 | 51 | 45 |
| Total debt | 161 | 160 | 22 |
| Total liabilities | 963 | 978 | 59 |
| -778 | -859 | 301 | |
| 64 | 81 | 37 | |
| – | – | -24.9% | |
| 12.3% | 11.2% | -38.8% |
Cash flow
| In millions of USD | 2023 | 2024 | 2025 |
|---|---|---|---|
| -76 | -69 | -54 | |
| 6 | 4 | 5 | |
| -83 | -73 | -59 | |
| Dividends paid | – | – | – |
| 0 | 0 | 0 | |
| 12 | 10 | 14 |
Valuation
- –
- –
- –
- 16.4×
- 24.2×
- –
- –
- -1.4%
- -2.7%
- 0.0%
Profitability
- 76.8%
- -36.4%
- -66.3%
- -45.7%
- -25.5%
- -25.5%
- 830.5%
- -32.5%
- -22.4%
- 37.9%
Growth
- +42.1%
- –
- +19.5%
- –
- −24.0%
Financial health
- -0.2×
- 0.07
- 7.7%
- -6.7×
- 5.20
- 5.57
- 0.56
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 18%of 946
Bottom 9%of 872
Top 14%of 868
Bottom 33%of 986
What analysts expect
- Average price target
- $38.00
- Range
- $38.00 – $38.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 14, 2026 | -0.16 | -0.18 | +11.1% |
| Mar 18, 2026 | -0.12 | -0.17 | +29.0% |
| Nov 12, 2025 | -0.27 | -0.20 | −35.0% |
| Sep 19, 2025 | -1.46 | -0.20 | −630.0% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
37No pass
Benjamin Graham
40No pass
Philip Fisher
54No pass
Peter Lynch
71Pass
Joel Greenblatt
0No pass
Charlie Munger
41No pass
Terry Smith
35No pass
Questions about Heartflow
Is Heartflow a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Heartflow AI analysis
What does Heartflow do?
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. It is in Health Information Services, based in San Francisco, CA, United States, with 843 employees.
Does Heartflow pay a dividend?
No. Heartflow does not pay a dividend at the moment.
Is Heartflow stock halal?
Yes. Heartflow passes our halal screen: its business is permitted and its debt is 0.5% of its market value, under the 30% limit. How we check
How has Heartflow stock done over the past year?
Up 77.4% over the past twelve months, to $48.46. It traded between $20.49 and $60.53 and is 19.9% below its high.
Who are Heartflow's competitors?
The largest listed companies in the same industry are Veeva Systems, Pro Medicus, Hinge Health and M3. The peers table on this page compares their profit, growth and price with Heartflow's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.